Previous research has indicated that selenium influences prostate cancer through various pathways, encompassing AR signaling, antioxidative properties, cell death, cell cycle regulation, angiogenesis, epigenetic regulation, immunoregulation, epithelial–mesenchymal transformation, and redox signaling. This evidence concerns the gene AR and prostate carcinoma.